title: Next generation anticoagulants may push warfarin to the wayside.
authors.affiliation: BKirsch@ManagedCareMag.com
authors.forename: Bob
authors.initials: B
authors.lastname: Kirsch
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000191:economics; D001562:Benzimidazoles / Q000009:adverse effects / Q000627:therapeutic use; D000069604:Dabigatran; D017277:Drug Approval; D004341:Drug Evaluation; D006801:Humans; D055118:Medication Adherence; D020521:Stroke / Q000188:drug therapy / Q000191:economics / Q000517:prevention & control; D014859:Warfarin / Q000009:adverse effects / Q000627:therapeutic use*; D015091:beta-Alanine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D001562:Benzimidazoles; D015091:beta-Alanine; D014859:Warfarin; D000069604:Dabigatran